HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Pierre Le Floch Selected Research

Neoplasms (Cancer)

6/2010Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Pierre Le Floch Research Topics

Disease

2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2016 - 01/2009
1Wounds and Injuries (Trauma)
01/2018
1Cognitive Dysfunction
02/2016
1Diabetes Complications
01/2016
1Type 2 Diabetes Mellitus (MODY)
10/2014
1Body Weight (Weight, Body)
10/2014
1Hypertension (High Blood Pressure)
01/2014
1Brain Ischemia (Cerebral Ischemia)
01/2014
1Heart Failure
01/2014
1Hypercholesterolemia
01/2014
1Ischemia
01/2014
1Neoplasms (Cancer)
06/2010
1Weight Gain
06/2010
1Hypoglycemia (Reactive Hypoglycemia)
06/2010
1Finger Injuries (Finger Injury)
10/2008

Drug/Important Bio-Agent (IBA)

4Insulin (Novolin)FDA Link
02/2016 - 06/2010
3Glucose (Dextrose)FDA LinkGeneric
01/2016 - 06/2010
2Insulin Aspart (NovoLog)FDA Link
10/2014 - 01/2009
2Insulin Detemir (Levemir)FDA Link
06/2010 - 01/2009
1InsulinsIBA
06/2010
1Blood Glucose (Blood Sugar)IBA
10/2008

Therapy/Procedure

2Therapeutics
06/2010 - 01/2009
1Surgical Amputation (Amputations)
01/2018
1Activities of Daily Living (ADL)
01/2014